¿Una UNGASS sin reducción de daños? ¡Imposible!


¿Una UNGASS sin reducción de daños? ¡Imposible!

3 febrero 2016
Peter Sarosi

Organizaciones de la sociedad civil denuncian que la falta de alusiones a la reducción de daños en el primer borrador del documento de resultados de la UNGASS representa un paso atrás con respecto a unos términos ya consensuados. Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.

The governments of the world are preparing for the United Nations General Assembly Special Session on drugs, in April this year - the first of its kind since 1998. Unfortunately, as I wrote in my previous essay on UNGASS, our politicians are far from accepting the reality that drugs are here to stay, and that it's time to change the punitive paradigm to a harm reduction paradigm. There is no hope that the international drug conventions - the cornerstone of global drug control - will be amended. The most we can expect is an outcome document which takes a stand against human rights abuses, speaks up for harm reduction, and is adopted with the meaningful involvement of civil society.

After several months of negotiation, the UNGASS board has come out with the first draft of the outcome document to be discussed and adopted in April by the member states. This document is a bitter disappointment for all of us who, in previous years, have invested our time and energy in advocacy around UN drug policies. Not because of what is included, but because of what is missing from the document - namely, any mention of harm reduction as such, or any specific harm reduction interventions, including needle and syringe programs, opiate substitution treatment or overdose prevention programs. As Harm Reduction International points out in its statement, this is not only a failure to move forward in the fight for a greater acceptance of harm reduction, but a significant step backwards from previously agreed language.

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.

Thumbnail: Harm Reduction Coalition